Shi‐Long Lu

4.4k total citations · 1 hit paper
63 papers, 3.3k citations indexed

About

Shi‐Long Lu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shi‐Long Lu has authored 63 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Shi‐Long Lu's work include TGF-β signaling in diseases (13 papers), Genetic factors in colorectal cancer (7 papers) and NF-κB Signaling Pathways (5 papers). Shi‐Long Lu is often cited by papers focused on TGF-β signaling in diseases (13 papers), Genetic factors in colorectal cancer (7 papers) and NF-κB Signaling Pathways (5 papers). Shi‐Long Lu collaborates with scholars based in United States, China and Japan. Shi‐Long Lu's co-authors include Xiao‐Jing Wang, Allen G. Li, Douglas D. Reh, Yoshimitsu Akiyama, Gangwen Han, Christopher L. Corless, Sanford D. Markowitz, Joseph Willis, Dawn Dawson and James Lutterbaugh and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Shi‐Long Lu

63 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CIP2A Inhibits PP2A in Human Malignancies

2007 533 citations Melissa R. Junttila, Pietri Puustinen et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi‐Long Lu United States	29	1.8k	1.1k	669	529	333	63	3.3k
Hao Xiong United States	29	2.0k 1.1×	1.6k 1.4×	377 0.6×	440 0.8×	210 0.6×	132	4.4k
Bora Lim United States	29	1.3k 0.7×	1.9k 1.7×	1.3k 2.0×	352 0.7×	252 0.8×	153	3.8k
Michael H. Muders Germany	30	1.3k 0.7×	904 0.8×	502 0.8×	136 0.3×	401 1.2×	79	2.7k
Geoffrey Bartholomeusz United States	24	2.0k 1.1×	1.1k 0.9×	482 0.7×	161 0.3×	234 0.7×	45	3.1k
Yin P. Hung United States	29	1.5k 0.8×	664 0.6×	430 0.6×	295 0.6×	213 0.6×	123	3.7k
Qiang Wang China	40	3.0k 1.6×	1.4k 1.3×	814 1.2×	252 0.5×	366 1.1×	191	5.3k
Philip M. Carpenter United States	26	1.3k 0.7×	652 0.6×	673 1.0×	383 0.7×	482 1.4×	73	3.3k
Christine Sers Germany	41	2.6k 1.4×	1.4k 1.2×	987 1.5×	417 0.8×	185 0.6×	114	4.5k
Jingnan Wang China	28	1.1k 0.6×	605 0.5×	709 1.1×	160 0.3×	192 0.6×	128	2.6k
Linbo Wang China	34	2.0k 1.1×	835 0.7×	1.5k 2.3×	179 0.3×	116 0.3×	140	4.1k

Countries citing papers authored by Shi‐Long Lu

Since Specialization

Citations

This map shows the geographic impact of Shi‐Long Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Long Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Long Lu more than expected).

Fields of papers citing papers by Shi‐Long Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Long Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Long Lu. The network helps show where Shi‐Long Lu may publish in the future.

Co-authorship network of co-authors of Shi‐Long Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Long Lu. A scholar is included among the top collaborators of Shi‐Long Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Long Lu. Shi‐Long Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Liwei, Ye Liu, Bo Chen, et al.. (2023). Metformin plays an antitumor role by downregulating inhibitory cells and immune checkpoint molecules while activating protective immune responses in breast cancer. International Immunopharmacology. 118. 110038–110038. 10 indexed citations

Chen, Haowei, Tianyu Chen, Jia Li, et al.. (2023). The application of machine learning in early diagnosis of osteoarthritis: a narrative review. Therapeutic Advances in Musculoskeletal Disease. 15. 1759720X231158198–1759720X231158198. 23 indexed citations

Frank, Daniel N., Yue Qiu, Yu Cao, et al.. (2022). A dysbiotic microbiome promotes head and neck squamous cell carcinoma. Oncogene. 41(9). 1269–1280. 50 indexed citations

Peng, Sheng, Shi‐Long Lu, Dongqiang Zeng, et al.. (2022). Prediction of knee pain improvement over two years for knee osteoarthritis using a dynamic nomogram based on MRI-derived radiomics: a proof-of-concept study. Osteoarthritis and Cartilage. 31(2). 267–278. 18 indexed citations

Fu, Shu-Ping, Dongqiang Zeng, Shi‐Long Lu, et al.. (2021). Predicting response to vitamin D treatment on osteoarthritis-A radiomics nomogram study based on magnetic resonance imaging. Osteoarthritis and Cartilage. 29. S347–S348. 3 indexed citations

Cao, Yu, Han Liu, Liwei Gao, et al.. (2018). Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression. Neoplasia. 20(8). 764–774. 9 indexed citations

Jiang, Shanshan, Hao Yu, Xianlong Wang, et al.. (2015). Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. European Radiology. 26(1). 64–71. 91 indexed citations

Frolova, Liliya V., Igor V. Magedov, Anntherese E. Romero, et al.. (2013). Exploring Natural Product Chemistry and Biology with Multicomponent Reactions. 5. Discovery of a Novel Tubulin-Targeting Scaffold Derived from the Rigidin Family of Marine Alkaloids. Journal of Medicinal Chemistry. 56(17). 6886–6900. 43 indexed citations

Malkoski, Stephen P., Timothy G. Cleaver, Joshua J. Thompson, et al.. (2013). Role of PTEN in basal cell derived lung carcinogenesis. Molecular Carcinogenesis. 53(10). 841–846. 17 indexed citations

10.

Malkoski, Stephen P., Sarah M. Haeger, Timothy G. Cleaver, et al.. (2012). Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma. Clinical Cancer Research. 18(8). 2173–2183. 52 indexed citations

11.

Zhao, Xüna, Zhibo Wen, Fanheng Huang, et al.. (2011). Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magnetic Resonance in Medicine. 66(4). 1033–1041. 134 indexed citations

12.

Malkoski, Stephen P., Timothy G. Cleaver, Shi‐Long Lu, Jessyka G. Lighthall, & Xiao‐Jing Wang. (2010). Keratin promoter based gene manipulation in the murine conducting airway. International Journal of Biological Sciences. 6(1). 68–79. 9 indexed citations

13.

Cohen, Jonah, Zhong Chen, Shi‐Long Lu, et al.. (2009). Attenuated Transforming Growth Factor β Signaling Promotes Nuclear Factor-κB Activation in Head and Neck Cancer. Cancer Research. 69(8). 3415–3424. 28 indexed citations

14.

Junttila, Melissa R., Pietri Puustinen, Minna Niemelä, et al.. (2007). CIP2A Inhibits PP2A in Human Malignancies. Cell. 130(1). 51–62. 533 indexed citations breakdown →

15.

Bornstein, Sophia, et al.. (2007). Distinct roles of individual Smads in skin carcinogenesis. Molecular Carcinogenesis. 46(8). 660–664. 16 indexed citations

16.

Han, Gangwen, Allen G. Li, Yao-Yun Liang, et al.. (2006). Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development. Developmental Cell. 11(3). 301–312. 129 indexed citations

17.

Lu, Shi‐Long, Heather Herrington, Douglas D. Reh, et al.. (2006). Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes & Development. 20(10). 1331–1342. 165 indexed citations

18.

Lu, Shi‐Long, et al.. (2005). Current View of the Role of Transforming Growth Factor β 1 in Skin Carcinogenesis. Journal of Investigative Dermatology Symposium Proceedings. 10(2). 110–117. 17 indexed citations

19.

Lu, Shi‐Long, Walter Bodemer, Christiane Ostwald, et al.. (2000). Anal Verrucous Carcinoma and Penile Condylomata acuminata. Dermatology. 200(4). 320–323. 7 indexed citations

20.

Lu, Shi‐Long, Yoshimitsu Akiyama, Hiromi Nagasaki, et al.. (1996). Loss or Somatic Mutations of hMSH2 Occur in Hereditary Nonpolyposis Colorectal Cancers with hMSH2 Germline Mutations. Japanese Journal of Cancer Research. 87(3). 279–287. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact